Pregnancy, Childbirth and the Puerperium, Phase III

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix (PROSPECT)

Volunteers
Health Professionals

What is the purpose of this trial?

This protocol outlines a randomized trial of 630 women evaluating the use of micronized vaginal progesterone or pessary versus control (placebo) to prevent early preterm birth in women carrying twins and with a cervical length of less than 30 millimeters.

Trial with
Women and Infants Hospital of Rhode Island
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Lauren Perley

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Christian Pettker, MD
Professor of Obstetrics, Gynecology and Reproductive Sciences; Chief Patient Safety Officer and Associate Chief Quality Officer, Yale Medicine and Yale New Haven Health; Chief of Obstetrics; Vice Chair of Quality, Obstetrics, Gynecology & Reproductive Sciences

Sub-Investigators

Last Updated
05/01/2024
Study HIC
#2000024771